Interview with Thomas R. Cech
“For them, it was a weird organism doing a weird thing”
In the interview, Thomas R. Cech discusses his groundbreaking discovery regarding the catalytic properties of…
GOOD NEWS We are on track and going into phase 2!
Even if it feels as if we had only just launched our NCCR RNA & Disease, it is an undeniable fact that we have already entered the 4th and…
Editorial Frédéric Allain - The Messenger No. 5
Dear colleagues, It is my pleasure to open this year’s first newsletter of the NCCR RNA & Disease. We are now finishing the third year of our…
Editorial Oliver Mühlemann - The Messenger No. 4
Dear colleagues,
I am glad to see how well by now our Newsletter has established itself as a source of valuable information for both the NCCR…
Editorial Thomas A. Cooper - The Messenger No. 3
Dear colleagues,
It’s happened, Daniel Schümperli has officially retired. Daniel’s research contributions have spanned nearly four decades and…
Editorial Witold Filipowicz - The Messenger No. 2
Dear colleagues,
The NCCR has entered its second year of activity and has just had its first Annual Retreat in Kandersteg, which brought together…
A noncanonical way out of pluripotency
Mouse embryonic stem cells (mESCs) deficient for DGCR8, a key component of the microprocessor complex, present strong differentiation defects. However, the…
Fostering the new generation of Swiss RNA researchers
A major goal of the NCCR RNA & Disease is to raise the next generation(s) of scientists in the field of RNA and Disease.
Besides training…
Identifying the drivers amongst the passengers
A new method developed by Rory Johnson, leader of the GOLD (Genomics of Long non- coding RNA and Disease) Lab at the at the University of Bern, can…
It is much easier to see unconscious bias in others, simply because we are not conscious of our own bias.
As scientists we all rely on the power of our brains to help us to make sense of data and…